155
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics

ORCID Icon, , , &
Pages 345-356 | Received 04 May 2017, Accepted 13 Sep 2017, Published online: 28 Sep 2017

References

  • Wani MC, Wall ME. Plant antitumor agents. II. Structure of two new alkaloids from Camptotheca acuminata. J Org Chem. 1969;34:1364–1367.
  • Wall ME, Wani MC, Cook CE, et al. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc. 2002;88:3888–3890.
  • Pommier Y, Pourquier P, Fan Y, et al. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta. 1998;1400:83–105.
  • Zhou JJ, Liu J, Xu B. Relationship between lactone ring forms of HCPT and their antitumor activities. Acta Pharmacol Sin. 2001;22:827–830.
  • Ding XQ, Wang AX, Kong QY, et al. Anticancer effect of hydroxycampothecin on oral squamous carcinoma cell line. Chin J Cancer. 2002;21:388–391.
  • Kim TE, Park SY, Hsu CH, et al. Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines. Mol Pharmacol. 2004;66:285–292.
  • Pu X, Sun J, Wang Y, et al. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Int J Pharm. 2009;379:167–173.
  • Yang L, Cui F, Cun D, et al. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm. 2007;340:163–172.
  • Zhou B, Wu Y, He W, et al. Preparation of nanoliposome coated with hydroxycamptothecin and study on release in vitro. China Pharmacist. 2005;8:270–273.
  • Zhang LL, Feng JF, Chen MC, et al. Preparation and physicochemical characters of 10-hydroxycamptothecin long-circulated lyophilized liposomes. Chin J Pharm. 2007;38:245–248.
  • Xie X, Wen L, Hui L, et al. Ultrasound-responsive nanobubbles contained with peptide–camptothecin conjugates for targeted drug delivery. Drug Deliv. 2016;23:2756–2764.
  • Xie X, Yang Y, Lin W, et al. Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery. Colloids Surf B Biointerfaces. 2015;136:641–650.
  • Yang Y, Yang Y, Xie X, et al. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials. 2015;48:84–96.
  • Kim CS, Duncan B, Creran B, et al. Triggered nanoparticles as therapeutics. Nano Today. 2013;8:439–447.
  • Lin W, Xie X, Yang Y, et al. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy. Drug Deliv. 2016;23:3436–3443.
  • Yang Y, Xie X, Xu X, et al. Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy. Colloids Surf B Biointerfaces. 2016;146:607–615.
  • Ghosh R, Pradhan L, Devi YP, et al. Induction heating studies of magnetic nanoparticles capped with oleic acid and polyethylene glycol for hyperthermia. J Mater Chem. 2011;21:13388–13398.
  • Zheng FC, Chen QW, Hu L, et al. Synthesis of sulfonic acid-functionalized Fe3O4@C nanoparticles as magnetically recyclable solid acid catalysts for acetalization reaction. Dalton Trans. 2014;43:1220.
  • Müller M, Bockenheimer J, Zellenberg U, et al. Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients. Breast Cancer Res Treat. 2000;60:211–217.
  • Wei YH, Xu LZ, Shen Q, et al. Microdialysis: a technique for pharmacokinetic-pharmacodynamic studies of oncological drugs. Curr Pharm Biotechnol. 2009;10:631–640.
  • Zhao XD, Feng QM, Wang WQ. Preparation and surface modification of magnetic nano. Appl Chem Industry. 2010;39:171–174.
  • Yang X. Preparation and characteristics of lipophilic magnetic nanoparticles. J China Three Gorges Univ. 2008;30:110–112.
  • Ling JJ, Jin-Hui GU, Xie Y, et al. Preparation and target characteristic test of hydroxycamptothecin magnetic liposomes. Chin J Exp Tradition Med Form. 2012;18:19–23.
  • Ling JJ, Chen X. Internal standard method to determine the recovery of nicotine in microdialysis. Yao Xue Xue Bao = Acta Pharm Sin. 2010;45:632–635.
  • Wang A, Li S. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. BMC Biotechnol. 2008;8:1–7.
  • Yue NY, Wen ZW. Determination of lyophilized HCPT liposomes in rat plasma and its pharmacokinetic study. J Changsha Med Univ. 2016;48–52.
  • Zhang TM, Cao BS, Wang ZY, et al. Therapeutic efficacies of combination HIFU with paclitaxel thermosensitive liposomes on Lewis lung carcinoma in mice. Chin J Clin. 2012;6:852–856.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.